| Status | Study |
| Not yet recruiting |
Study Name: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers Condition: Adenoid Cystic Carcinoma Adnexal Carcinoma Apocrine Carcin Date: 2016-11-30 Interventions: Other: Laboratory Biomarker Analysis |
| Recruiting |
Study Name: Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition: Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Date: 2016-07-29 Interventions: Biological: Bevacizumab Given |
| Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
| Active, not recruiting |
Study Name: Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer Condition: Mucinous Adenocarcinoma of the Rectum Recurrent Rectal Cancer Date: 2014-10-16 Interventions: Radiation: intensity-modulated radiation therapy |
| Withdrawn |
Study Name: Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Condition: Mucinous Adenocarcinoma of the Colon Muci Date: 2014-09-04 Interventions: Biological: ziv-aflibercept Gi |
| Recruiting |
Study Name: CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery Condition: Mucinous Adenocarcinoma of the Colon Muci Date: 2014-09-02 Interventions: Drug: 6,8-bis(benzylthio)octanoic acid |
| Recruiting |
Study Name: Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation Condition: Mucinous Adenocarcinoma of the Rectum Recurrent Rectal Cancer Date: 2014-05-06 Interventions: Other: cytology specimen collection procedure |
| Recruiting |
Study Name: Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver Condition: Liver Metastases Mucinous Adenocarcinoma of the Colon Date: 2014-04-08 Interventions: Combination Product: irinotecan-eluting beads |
| Recruiting |
Study Name: MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer Condition: Malignant Ovarian Brenner Tumor Ovarian Clear Cell Adenocarcinoma Date: 2014-02-19 Interventions: Other: Laboratory Biomarker Analysis |
| Recruiting |
Study Name: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers Condition: Cervical Adenosarcoma Cervical Adenosquamous Carcinoma Cer Date: 2013-12-19 Interventions: Biological: Bevacizumab Given |